review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Sandra Jeremias dos Santos Catarino | Q56946998 |
Angelica Beate Winter Boldt | Q77668062 | ||
Iara Jose de Messias-Reason | Q98393146 | ||
Isabela Goeldner | Q115138632 | ||
P2093 | author name string | Marcia Holsbach Beltrame | |
P2860 | cites work | Non-synonymous polymorphisms in the FCN1 gene determine ligand-binding ability and serum levels of M-ficolin | Q21133812 |
Proteolytic activities of two types of mannose-binding lectin-associated serine protease | Q24290100 | ||
MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway | Q24291529 | ||
Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation | Q24299377 | ||
L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement | Q24304072 | ||
A second serine protease associated with mannan-binding lectin that activates complement | Q24311275 | ||
A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin | Q24318926 | ||
Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway | Q24337732 | ||
MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes | Q24607800 | ||
Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome | Q24613690 | ||
A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation | Q24633142 | ||
Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology | Q24647006 | ||
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells | Q24670661 | ||
The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10 | Q24681840 | ||
The role of complement system in septic shock | Q27027974 | ||
Local inflammation induces complement crosstalk which amplifies the antimicrobial response | Q27318134 | ||
Structure of a C-type mannose-binding protein complexed with an oligosaccharide | Q27642164 | ||
Trivalent recognition unit of innate immunity system: crystal structure of trimeric human M-ficolin fibrinogen-like domain | Q27643220 | ||
Carbohydrate Recognition Properties of Human Ficolins: GLYCAN ARRAY SCREENING REVEALS THE SIALIC ACID BINDING SPECIFICITY OF M-FICOLIN | Q27658764 | ||
Monospecific Inhibitors Show That Both Mannan-binding Lectin-associated Serine Protease-1 (MASP-1) and -2 Are Essential for Lectin Pathway Activation and Reveal Structural Plasticity of MASP-2 | Q27678585 | ||
The X-ray Crystal Structure of Mannose-binding Lectin-associated Serine Proteinase-3 Reveals the Structural Basis for Enzyme Inactivity Associated with the Carnevale, Mingarelli, Malpuech, and Michels (3MC) Syndrome | Q27678744 | ||
Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family | Q28115725 | ||
Mannose-binding lectin polymorphisms in clinical tuberculosis | Q28203157 | ||
Complement. First of two parts | Q28210663 | ||
Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype | Q28238306 | ||
Genetic and structural analysis of MBL2 and MASP2 polymorphisms in south-eastern African children | Q28259433 | ||
MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation | Q28264948 | ||
Coding and non-coding polymorphisms in the lectin pathway activator L-ficolin gene in 188 Dutch blood bank donors | Q28265418 | ||
L-ficolin is a pattern recognition molecule specific for acetyl groups | Q28279109 | ||
Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation | Q28286627 | ||
Biological variations of MASP-3 and MAp44, two splice products of the MASP1 gene involved in regulation of the complement system | Q28289357 | ||
Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease | Q28294642 | ||
The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels | Q28294974 | ||
Stoichiometry of complexes between mannose-binding protein and its associated serine proteases. Defining functional units for complement activation | Q28574745 | ||
Molecular determinants of oligomer formation and complement fixation in mannose-binding proteins | Q28575621 | ||
Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition | Q28610880 | ||
Serum concentration of Hakata antigen, a member of the ficolins, is linked with inhibition of Aerococcus viridans growth | Q28610896 | ||
Human M-ficolin is a secretory protein that activates the lectin complement pathway | Q28610924 | ||
The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection | Q28727502 | ||
Complement: a key system for immune surveillance and homeostasis | Q29615484 | ||
Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2 | Q30519464 | ||
Posttranslational modifications in human plasma MBL and human recombinant MBL. | Q33272929 | ||
Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes | Q33577516 | ||
Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin | Q33795274 | ||
Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile | Q33862372 | ||
Changes in the mannan binding lectin (MBL) concentration in human milk during lactation. | Q33962411 | ||
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis | Q34008749 | ||
The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma | Q34010473 | ||
Relevance of the lectin pathway of complement in rheumatic diseases | Q34031016 | ||
Complement and its role in innate and adaptive immune responses | Q34088142 | ||
Collections and ficolins: humoral lectins of the innate immune defense | Q34169976 | ||
Ficolins in complement activation | Q38041820 | ||
Toward a structure-based comprehension of the lectin pathway of complement | Q38126258 | ||
If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it? | Q38164341 | ||
Ficolins and infectious diseases | Q38180985 | ||
A vital role for complement in heart disease | Q38231108 | ||
Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms | Q38305434 | ||
Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers | Q38310018 | ||
MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection. | Q38332617 | ||
Mannose-binding lectin without the aid of its associated serine proteases alters lipopolysaccharide-mediated cytokine/chemokine secretion from human endothelial cells | Q38505801 | ||
Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus | Q38913652 | ||
Association of a new mannose-binding lectin variant with severe malaria in Gabonese children | Q38913656 | ||
Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy | Q38966320 | ||
The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm | Q38966324 | ||
Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria | Q38997834 | ||
Recognition of plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system | Q39140090 | ||
Schistosoma mansoni: adhesion of mannan-binding lectin to surface glycoproteins of cercariae and adult worms | Q39140094 | ||
Anti-endothelial cell antibodies in rheumatic heart disease | Q39196176 | ||
Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease | Q39247371 | ||
Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma | Q39717405 | ||
M-ficolin in the neonatal period: Associations with need for mechanical ventilation and mortality in premature infants with necrotising enterocolitis | Q39835929 | ||
Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity | Q39881059 | ||
Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state | Q40015050 | ||
Functional MASP2 gene polymorphism in patients with history of rheumatic fever | Q40120882 | ||
Association of MASP2 polymorphisms and protein levels with rheumatic fever and rheumatic heart disease | Q40186841 | ||
Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women | Q40298826 | ||
The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. | Q40462107 | ||
Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency | Q40521039 | ||
Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study | Q40536982 | ||
Human mannose-binding protein gene is regulated by interleukins, dexamethasone and heat shock | Q41530914 | ||
The alternative pathway C3/C5 convertase: chemical basis of factor B activation | Q41688985 | ||
L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway | Q41911504 | ||
The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. | Q41939432 | ||
Lectin pathway of complement activation and relation with clinical complications in critically ill children | Q42244078 | ||
Mannose binding lectin and mannose binding lectin-associated serine protease-2 genes polymorphisms in human T-lymphotropic virus infection. | Q42283356 | ||
Mice deficient in ficolin, a lectin complement pathway recognition molecule, are susceptible to Streptococcus pneumoniae infection | Q42286620 | ||
Heart valve structure: a predisposing factor for rheumatic heart disease | Q42830829 | ||
Functional estimation of mannose binding lectin associated serine protease (MBL-MASPs) in human serum. | Q43234844 | ||
Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP. | Q43278864 | ||
Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury | Q43740164 | ||
Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles | Q44096290 | ||
Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases. | Q44400729 | ||
L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children | Q44437093 | ||
Inherited deficiency of mannan-binding lectin-associated serine protease 2. | Q44540603 | ||
Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement | Q44840259 | ||
Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality | Q45299103 | ||
Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. | Q46477709 | ||
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein | Q46487298 | ||
Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism | Q46692780 | ||
L-ficolin binding and lectin pathway activation by acetylated low-density lipoprotein. | Q46887320 | ||
Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components | Q47659798 | ||
Phospholipid-binding activity of human mannan-binding lectin | Q47872158 | ||
L-ficolin in children with recurrent respiratory infections | Q47895660 | ||
Innate immune collectins bind nucleic acids and enhance DNA clearance in vitro | Q47916786 | ||
Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis | Q49037435 | ||
Polymorphisms in the lectin pathway genes as a possible cause of early chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients. | Q49155500 | ||
Investigations on the pattern recognition molecule M-ficolin: quantitative aspects of bacterial binding and leukocyte association | Q50335844 | ||
Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. | Q50785735 | ||
Ficolin-1-PTX3 complex formation promotes clearance of altered self-cells and modulates IL-8 production. | Q50865174 | ||
Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. | Q51829664 | ||
Increased complement classical and mannan-binding lectin pathway activities in schizophrenia. | Q51914518 | ||
Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. | Q53368984 | ||
Serum lectin with known structure activates complement through the classical pathway. | Q53877303 | ||
MAp19, the alternative splice product of the MASP2 gene. | Q54351972 | ||
MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. | Q54378107 | ||
Humoral pattern recognition and the complement system. | Q34344598 | ||
Mannose-binding lectin deficiency is associated with myocardial infarction: the HUNT2 study in Norway | Q34359560 | ||
The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription | Q34375499 | ||
M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement | Q34469825 | ||
The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells | Q34624161 | ||
Association of L-ficolin levels and FCN2 genotypes with chronic Chagas disease | Q34672811 | ||
Association of ficolin-3 with severity and outcome of chronic heart failure | Q34676160 | ||
High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever | Q34792551 | ||
Leprosy association with low MASP-2 levels generated by MASP2 haplotypes and polymorphisms flanking MAp19 exon 5 | Q34919024 | ||
Polymorphisms in the MASP1 gene are associated with serum levels of MASP-1, MASP-3, and MAp44 | Q34984382 | ||
A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins | Q35089426 | ||
Anti-microbial activities of mannose-binding lectin | Q35187396 | ||
Mannan binding lectin deficiency and concomitant immunodefects | Q35258823 | ||
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? | Q35741515 | ||
Complement activation after oxidative stress: role of the lectin complement pathway | Q35810112 | ||
Human L-ficolin (ficolin-2) and its clinical significance | Q35829788 | ||
MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans | Q35848395 | ||
Mutations of complement lectin pathway genes MBL2 and MASP2 associated with placental malaria | Q35873505 | ||
Mannan-binding-lectin-associated serine proteases, characteristics and disease associations | Q36270453 | ||
A population-based study of morbidity and mortality in mannose-binding lectin deficiency | Q36399188 | ||
Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk | Q36402570 | ||
Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions | Q36565247 | ||
Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins | Q36927870 | ||
A role of macrophage complement receptor CRIg in immune clearance and inflammation. | Q37254633 | ||
Degradome expression profiling in human articular cartilage | Q37270886 | ||
Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation | Q37382867 | ||
The complement system in systemic autoimmune disease | Q37652141 | ||
Molecular defects in the mannose binding lectin pathway in dermatological disease: Case report and literature review. | Q37718970 | ||
The genetics of ficolins | Q37726757 | ||
Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation | Q37728717 | ||
The lectin pathway and its implications in coagulation, infections and auto-immunity | Q37819940 | ||
Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis. | Q37867614 | ||
Disease-causing mutations in genes of the complement system | Q37888153 | ||
Mannan-binding lectin deficiency - Good news, bad news, doesn't matter? | Q37989272 | ||
[Mannose-binding lectin gene site mutations and the susceptibility of rheumatic heart disease] | Q54638889 | ||
Assignment 1 of the gene encoding mannan-binding lectin-associated serine protease 2 (MASP2) to human chromosome 1p36.3→p36.2 by in situ hybridization and somatic cell hybrid analysis | Q57631380 | ||
Low clinical penetrance of mannose-binding lectin–associated serine protease 2 deficiency | Q58840837 | ||
Stable bronchiectasis is associated with low serum L-ficolin concentrations | Q61946549 | ||
Association between lectin complement pathway initiators, C-reactive protein and left ventricular remodeling in myocardial infarction—A magnetic resonance study | Q63728000 | ||
Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation | Q63728017 | ||
The Ficolins | Q63728045 | ||
Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen) | Q63728053 | ||
Association of mannose-binding-lectin deficiency with severe atherosclerosis | Q63728133 | ||
Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 —a prognostic marker in colorectal cancer | Q63753489 | ||
Biological Variation in Circulating Levels of Mannan-Binding Lectin (MBL) and MBL-Associated Serine Protease-2 and the Influence of Age, Gender and Physical Exercise | Q63753498 | ||
Characterization of the initial C3 convertase of the alternative pathway of human complement. | Q64902892 | ||
Molecular basis of opsonic defect in immunodeficient children | Q68303831 | ||
Age-dependent variation in the serum concentration of mannan-binding protein | Q71668573 | ||
Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 Mr component of the Clq receptor | Q71800454 | ||
Oligomeric Structures Required for Complement Activation of Serum Mannan- Binding Proteins | Q71869104 | ||
Perinatal changes in serum mannose-binding protein (MBP) levels | Q72286605 | ||
Human L-ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain | Q74480915 | ||
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction | Q79255657 | ||
The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier | Q79257224 | ||
Two factors of the lectin pathway of complement, l-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates | Q79702427 | ||
Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms | Q80109537 | ||
Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection | Q80442215 | ||
Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells | Q80475635 | ||
Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury | Q81880380 | ||
Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis | Q82034898 | ||
Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease | Q82132661 | ||
The mannan-binding lectin (MBL) pathway of complement activation: biochemistry, biology and clinical implications | Q82210722 | ||
M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy | Q83210102 | ||
Mannan-binding lectin (MBL) and MBL-associated serine protease-2 in children with cancer | Q83995289 | ||
Involvement of lectin pathway activation in the complement killing of Giardia intestinalis | Q84036147 | ||
Multiple routes of complement activation by Mycobacterium bovis BCG | Q84448113 | ||
P304 | page(s) | 148 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | Frontiers in pediatrics | Q27725038 |
P1476 | title | The lectin pathway of complement and rheumatic heart disease | |
P478 | volume | 2 |
Q91672533 | Association of ficolin-2 (FCN2) functional polymorphisms and protein levels with rheumatic fever and rheumatic heart disease: relationship with cardiac function |
Q98177756 | Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option |
Q50916067 | Complement Recognition Pathways in Renal Transplantation. |
Q40130525 | Editorial: Frontiers in Autoimmune Disease: Rheumatic Fever and Rheumatic Heart Disease |
Q95840971 | Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage |
Q51281718 | Lectin complement pathway proteins in healthy individuals. |
Q40253064 | Lectin pathway factors in patients suffering from juvenile idiopathic arthritis |
Q52589514 | MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study. |
Q50321173 | Particulate matter, the newborn methylome, and cardio-respiratory health outcomes in childhood. |
Q60949701 | Sickening or Healing the Heart? The Association of Ficolin-1 and Rheumatic Fever |
Q52311676 | Sparking Fire Under the Skin? Answers From the Association of Complement Genes With Pemphigus Foliaceus. |
Q47819414 | Structural and functional diversity of collectins and ficolins and their relationship to disease. |
Q39284836 | The Complement System: A Prey of Trypanosoma cruzi |
Q38650723 | The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis |
Q91907252 | The innate immune response to allotransplants: mechanisms and therapeutic potentials |
Q38850689 | Trichocysts-Paramecium's Projectile-like Secretory Organelles: Reappraisal of their Biogenesis, Composition, Intracellular Transport, and Possible Functions |
Search more.